Monday, March 22, 2021 8:11:49 PM
Here is what Deitsch has done for NPHC in 19 years:
Added Many patents and trademarks to Nutra's portfolio
Clinical Trials in Multiple Phases
1. Multiple Sclerosis Trials
2. Herpes Simplex Infections 1 & 2 Trials
3. Adrenomyeloneuropathy Trials
4. HIV Trials
5. Amyotrophic Lateral Sclerosis Trials
6. Rheumatoid Arthritis Trials
7. Pain Trials
Products launched and brought to Market
1. Cobroxin
2. Nyloxin
3. Pet Pain Away
4. Equine pain Away
Published Research
http://receptopharm.com/drug_development/published_research.php
https://www.nutrapharma.com/research
Increased Sales on Amazon and Walmart
RPI-78M has received Orphan Drug Designation from the FDA for the treatment of Pediatric Multiple Sclerosis
Huge personal loans from Deitsch to NPHC tells me the CEO knows and believes in NPHC
Truth hurts...Being Short in NPHC hurts even more...
I guess some people have a different definition of accomplished anything!!
Added Many patents and trademarks to Nutra's portfolio
Clinical Trials in Multiple Phases
1. Multiple Sclerosis Trials
2. Herpes Simplex Infections 1 & 2 Trials
3. Adrenomyeloneuropathy Trials
4. HIV Trials
5. Amyotrophic Lateral Sclerosis Trials
6. Rheumatoid Arthritis Trials
7. Pain Trials
Products launched and brought to Market
1. Cobroxin
2. Nyloxin
3. Pet Pain Away
4. Equine pain Away
Published Research
http://receptopharm.com/drug_development/published_research.php
https://www.nutrapharma.com/research
Increased Sales on Amazon and Walmart
RPI-78M has received Orphan Drug Designation from the FDA for the treatment of Pediatric Multiple Sclerosis
Huge personal loans from Deitsch to NPHC tells me the CEO knows and believes in NPHC
Truth hurts...Being Short in NPHC hurts even more...
I guess some people have a different definition of accomplished anything!!
he hasn't accomplished anything of value in 19 years
Nyloxin, I put that Sh*t on everything!!! $NPHC
Recent NPHC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/06/2026 09:10:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/25/2026 06:38:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/11/2026 07:22:37 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/17/2026 07:11:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/02/2026 06:52:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/23/2025 06:15:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/17/2025 10:08:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/24/2025 06:48:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/28/2025 08:02:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/23/2025 05:43:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/16/2025 08:38:46 PM
